OUR WEBINARS
October 2020
A Patient’s Journey With Atopic Dermatitis
Adam Friedman
MD, FAAD
Professor and Interim Chair of Dermatology
Residency Program Director
Director of Transnational Research
Director of Supportive Oncodermatology Clinic
Department of Dermatology
George Washington School of Medicine and Health Sciences
Jason Lee-LLacer And Agnes Abedela, RN, MSN
MD
Jason Lee-LLacer is a Critical Care
Medicine Specialist in Lanham MD
Details :
TUESDAY OCT 13, 2020 at 7:00PM EDT Join us for a live webinar for a panel discussion between Adam Friedman, MD and his patient, Jason Lee-Llacer, MD and his wife Agnes Abedela, RN, as they discuss his struggle with severe atopic dermatitis. This includes the various drug and adjunctive therapies used to treat and manage his condition. This panel discussion will include Q&A. Jason Lee-Llacer, MD and Agnes Abedela, RN are ICU health care providers. His AD caused severe QOL concerns, including loss of sleep, which impacted his work and social life. Part of Dr. Lee-Llacer’s treatment included two weeks of balneotherapy at the Thermal Dermatology center in La Roche-Posay, France.
Description:
The first part of this webinar will address the pathogenesis of hyperhidrosis and its psychosocial impact on our patients as well as emerging treatment options.
The second part of the webinar will discuss the use of Ixekizumab for psoriasis and psoriatic arthritis patients with a focus on its new pediatric indication in psoriasis.
October 2020
INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES
Leon Kircik
MD, FAAD
Details :
Tuesday October 6th, 2020 from 7:00PM- 8:00PM EDT Join us for these important discussions
September 2020
Skin Barrier Integrity and Skin of Color: What you need to know!
Heather Woolery-Lloyd
MD, FAAD
Director, Skin of Color Division
Dr Phillip Frost Department of
Dermatology and Cutaneous Surgery
University of Miami
Miller School of Medicine
Andrew F. Alexis
MD, MPH
Director, Skin of Color Center
Chair, Department of Dermatology
Mount Sinai Morningside and
Mount Sinai West
Professor, Icahn School of Medicine
at Mount Sinai
Details :
TUESDAY SEPTEMBER 29TH, 2020 at 7:00PM EDT Please join us for our next important webinar provided by CeraVe and RBC Consultants.
This presentation will cover what you need to know about the role of the skin barrier in the skin of color patient. Although conflicting data exists, several studies have confirmed key differences in the skin barrier when comparing different ethnicities. We will discuss both the clinical and cultural significance of moisturizers in skin of color patients. We will also decode moisturizer ingredients offering insights into the specific role of common key ingredients in moisturizer formulations.
September 2020
Newborn and Infant Skincare: Update on Sensitive Skin Care and Barrier function: What you need to know!
Lawrence Schachner
MD, FAAD, FAAP
Stiefel Professor
Chairman Emeritus Dermatology
Professor of Dermatology and Pediatrics
Director of Pediatric Dermatology
University of Miami School of Medicine
Peter Lechman
MD, MBA, FAAP
Associate Chief Medical Officer for Primary Care
Medical Director, Primary Care and Pediatrics
Northwestern Medical Group
Instructor of Clinical Pediatrics at
Northwestern University Feinberg School of Medicine
Attending Physician at the
Anne and Robert H. Lurie Children’s Hospital of Chicago
This presentation will provide what you need to know about the role of newborn and infant skincare in promoting important short-term and long-term health benefits to your patients. The skin of babies is still undergoing maturation during the first days, weeks, months and early years of life.
Appropriate skin care can help this maturation in barrier function and structure, decrease skin sensitivity and potentially halt the atopic march towards systemic allergic disease. We will discuss the barrier maturation and function of babies skin, simple but effective care, as well as potential transcutaneous toxicities to avoid.
August 2020
The Role of Ceramides in Skin Barrier Integrity: What You Need to Know!
Daniela P. Antelo
MD, MSC, PhD
Adjunct Professor of Dermatology
Universidade do Estado
Rio de Janeiro, Brazil
Chief of Cosmetic Dermatology
Sector of
Hospital Universitario Pedro Ernesto
Master Degree and PhD at
Dermatology
Federal University of Rio de Janeiro
Carmen Gloria Gonzalez
MD
Pediatric Dermatologist
Fellowship in Pediatric Dermatology
Feinberg School of Medicine.
Northwestern University
Member of American Academy of Dermatology
Society in Pediatric Dermatology and
European Society of Pediatric Dermatology
Associate Editor of Practical and
Conceptual Dermatology Journal
We wanted to thank everyone for attending our most recent educational webinar, The Role of Ceramides in Skin Barrier Integrity: What You Need to Know!
Dr. Daniela P. Antelo and Dr. Carmen Gloria Gonzalez both delivered excellent talks on skin barrier anatomy and function and effectiveness of Ceramide use in dermatology.
July 2020
A Forgotten Concept: pH and Skin Barrier
Leon Kircik
MD
Professeur clinique de dermatologie
École de médecine Icahn à Mount Sinai, NY
Directeur médical
Sciences de la peau, Louisville, KY
Charles W. Lynde
MD
Directeur médical
Le Lynde Institute for Dermatology &
Recherche Lynderm Inc.
professeur agrégé
Université de Toronto, Département de médecine
Details :
August 12th, 2020 at 8:00PM EDT
In this LIVE webinar, Leon Kircik, MD, FAAD and Charles Lynde, MD, FRCPC, will be reviewing the role of skin surface pH in skin barrier function as well as the challenges in balancing pH in atopic dermatitis and acne patients.
They will also be providing clinical insights into the role of skin pH in AD and acne patients as well as clinical data on the importance of moisturizers and cleansers in skin barrier function.
Watch our Webinar with Dr. Charles W. Lynde and Dr. Leon Kircik
Click on the Youtube logo to subscribe to our channel for our upcoming Webinars.
July 2020
INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES
Leon Kircik
MD, FAAD
Face and Hands:
Insights into the
Impact of COVID-19
on Skin Barrier Integrity
Linda Stein Gold
MD
Progress Your
Topical Patients to
the Next Step:
An Oral Treatment
With Data for
Moderate to Severe
Scalp Psoriasis
Doris Day
MD, FAAD
Professeur clinique de dermatologie
École de médecine Icahn à Mount Sinai, NY
Directeur médical
Sciences de la peau, Louisville, KY
Details :
Thursday Jul 30th, 2020 from 8:00PM- 9:00PM EDT
- Amidst the use of personal protection equipment (PPE) during COVID 19 pandemic, we are discovering the indirect impact of the virus on our skin.
- During this session, Dr. Leon Kircik will discuss the relevant cutaneous findings and the disruption of barrier function caused with the extensive use of masks, hand sanitizers, and other PPE . We will emphasize the importance of barrier restoration with unique ceramide formulation skincare as well as the importance of maintaining natural skin pH.
- In addition, Dr. Linda Stein Gold will present on how to progress your topical patients to the next step with an oral treatment with data for moderate to severe scalp psoriasis.
-Dr Doris Day will review systemic and local effects of stress on the hair follicle and the benefits of proactive interventions.
July 2020
Comment naviguer dans le paysage changeant de la dermatologie et des relations de l'industrie après la pandémie
Chair: Marc Bourcier
MD
Professeur adjoint d’enseignement
clinique de la faculté de médecine et des
sciences de la santé de
l’Université de Sherbrooke
Charles W. Lynde
MD
Directeur médical
Le Lynde Institute for Dermatology &
Recherche Lynderm Inc.
professeur agrégé
Université de Toronto, Département de médecine
Leon Kircik
MD
Professeur clinique de dermatologie
École de médecine Icahn à Mount Sinai, NY
Directeur médical
Sciences de la peau, Louisville, KY
Objectifs :
Mercredi le 29 Juillet, 2020 from 8:00PM- 9:00PM EDT
- Dans ce webinaire interactif en direct, le Dr Marc Bourcier partagera son point de vue sur la façon dont l’ère post COVIDE-19 aura un impact sur l’interaction de la communauté dermatologique avec l’industrie. Un groupe de dirigeants clés de l’industrie discutera de la façon dont l’industrie s’adapte à la situation pendant la pandémie de Covide-19 afin de répondre aux besoins de la communauté dermatologique au Québec. En outre, un leader d’opinion clé, le Dr Charles Lynde, partagera une perspective plus poussée du restant du Canada et le Dr Leon Kircik, partagera une perspective plus poussée du sud de la frontière. Un niveau élevé d’interactivité sera intégré à plusieurs questions de sondage et à une longue période de questions-réponses. Cette séance offrira a la communauté dermatologique et aux chefs de file de l’industrie l’occasion de mieux comprendre et d’explorer la façon de naviguer dans la « nouvelle normalité » pour les relations futures.
Altius Healthcare
Sybil Dahan
Présidente
Bausch Health
Richard Lajoie
President, Canada
Dermtek Pharma
Michel Lavoie
Président
Galderma Canada
Wendy Adams
Directeur général Canada
July 2020
For a Webinar discussing Antibiotics, Probiotics and Antibiotic Stewardship in the SARS-COV 2 ERA
Ellie Goldstein
MD
Stuart Johnson
MD
Ravina Kullar
PharmD
Lynne McFarland
PhD
The COVID 19 pandemic has locked down countries and stressed hospital systems worldwide. Patients who are admitted to the hospital, especially those with respiratory complications, are frequently placed on empirical antibiotics in part due to the fear of aerosolization of the virus, despite limited data showing low rates of bacterial and fungal infections. When patients get sicker, antibiotics are often empirically escalated, creating an inherent dilemma for the hospital’s Antimicrobial Stewardship program (ASP). The additional use of antibiotics, especially in ICU patients, can potentially lead to drug toxicities, allergies, prolonged hospital stays, increased bacterial resistance and associated complications such as C. difficile infection (CDI). CDI, with 428,000 cases per year with 5.2% attributable mortality, costs insurers approximately $5 billion dollars (US) in excess medical costs and is considered an urgent global threat by the WHO and CDC. Hospital ASP teams have begun to lower these rates with more restrictive antibiotic use protocols. The use of specific strains of probiotics has been shown to effectively reduce antibiotic-associated diarrhea and CDI in several randomized controlled trials (RCTs), but not all probiotic strains or mixtures are effective. An innovative strategy which involves administering specific probiotics to every inpatient who receives an antibiotic and continuing the probiotic for the duration of the antibiotic course or until discharge is proposed as an essential element of an effective CDI prevention bundle.
July 2020
How to navigate the changing landscape of dermatology and industry relationships post pandemic
Charles W. Lynde
MD
Medical Director, The Lynde Institute for
Dermatology& Lynderm Research Inc.
Associate Professor, University of Toronto,
Department of Medicine
Chair: Leon Kircik
MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, NY
Medical Director, Skin Sciences, Louisville, KY
Details
Thursday, July 23st, 2020 from 7:00PM- 8:30PM EDT
- In this live webinar, Charles W. Lynde, MD, and Leon Kircik, MD will lead the discussion on how the post-COVID-19 era will impact the future of the dermatology industry relationship. A panel of key pharmaceutical executives will discuss their perspective of the future of dermatology and how the industry is changing to adapt to serve the needs of the dermatology community. A high level of interaction will be incorporated with several polling questions and an extensive Q&A period.
This session will offer both dermatology health care professionals and industry leaders an opportunity to better understand and explore how to navigate the “new normal”.
Bausch Health
Richard Lajoie
President, Canada
Galderma Canada
Wendy Adams
General Manager
Novartis Pharmaceuticals
Andrea Marazzi
Country Pharma Organization Head
UCB Canada
Jerry Syrotuik
Scientific Head of Immunology
July 2020
How to navigate the changing landscape of dermatology and industry relationships post pandemic
Chair: Leon Kircik
MD
Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, NY
Medical Director, Skin Sciences, Louisville, KY
Mark Lebwohl
MD
Professor And Chairman
Kimberly and Eric J. Waldman
Department of Dermatology
Icahn School of Medicine at Mount Sinai
Charles W. Lynde
MD
Medical Director, The Lynde Institute for
Dermatology& Lynderm Research Inc.
Associate Professor, University of Toronto,
Department of Medicine
Details
Tuesday, July 21st, 2020 from 7:00PM- 8:30PM EDT
- In this live webinar, Leon Kircik, MD and Mark Lebwohl, MD will lead the discussion on how the post-COVID-19 era will impact the future of dermatology industry relationship. A panel of key pharmaceutical executives will discuss their perspective of the future of dermatology and how the industry is changing to adapt to serve the needs of the dermatology community. A high level of interaction will be incorporated with several polling questions and an extensive Q&A period. We will also have a guest ,Dr Charles Lynde from Canada who will give us Canadian viewpoint.
This session will offer both dermatology health care professionals and industry leaders an opportunity to better understand and explore how to navigate the “new normal” .
Arcutis Biotherapeutics
Frank Wantanabe
President and CEO
Bausch Health
Richard Lajoie
President, Canada
Brickell Biotech
Robert Brown
CEO
Cassiopea
Diana Harbort
CEO
Dermavant
Todd Zavodnick
CEO
Leo Pharma
Chris Posner
President and CEO
Lilly
Becki Morison
Immunology Leader USA
Novartis
Victor Bulto
President
Ortho Dermatologics
Bill Humphries
President
UCB
Rhonda Peebles
Head US Dermatology
July 2020
Face and Hands: Insights Into The Impact of COVID-19 on Skin Barrier Integrity
Dr. Charles W. Lynde
MD, FRCPC, DABD, FCDA
Dr. Leon Kircik
MD, FAAD
Details
Wednesday, July 15th 2020 from 7:00PM- 8:00PM
- Amidst the use of personal protection equipment (PPE) during the COVID 19 pandemic, we are discovering the indirect impact of the virus on our skin.
- During this session, we will discuss the relevant cutaneous findings and the disruption of barrier function caused by the extensive use of masks, hand sanitizers, and other PPE. We will emphasize the importance of barrier restoration with unique ceramide formulation skincare as well as the importance of maintaining natural skin pH.
FREE GIFTS TO ALL ATTENDEES
Watch our Webinar with Dr. Charles W. Lynde and Dr. Leon Kircik
Click on the Youtube logo to subscribe to our channel for our upcoming Webinars.
July 2020
Mieux Connaître l’Hidradénite Suppurée
Modératrice
Dre Isabelle Delorme
MD, FRCPC, Dermatologue
Conférencière
Dre Hélène Veillette
MD, FRCPC, Dermatologue
Objectifs :
Lundi le 13 juillet 2020 de 19h00 à 20h00
- Sensibiliser les participants aux divers aspects du tableau clinique de la H.S. afin de raccourcir le délai diagnostic
- Mieux connaître la réalité vécue par les personnes atteintes de la H.S. et l’incidence de la maladie sur leur qualité de vie
- Assurer le traitement approprié grâce à une prise en charge collaborative et orienter au besoin le patient vers un dermatologue